Lung Cancer
-
NTRK Fusions, What’s Next? A Discussion on the Current Landscape of NTRK Fusion Therapeutic Management
Martin F. Dietrich, MD, PhD
-
Perioperative Therapy and esNSCLC – ALINA Improves Outcomes for ALK Mutated NSCLCs
Charu Aggarwal, MD, MPH; Eric Vallieres, MD
-
Perioperative Therapy in Early Stage NSCLC – Implications for Molecular Testing
Charu Aggarwal, MD, MPH; Brendon M. Stiles, MD
-
Adjuvant therapy for Early Stage Lung Cancer – Case Based Discussion for Patient with Stage 1B NSCLC
Charu Aggarwal, MD, MPH; John Kucharczuk, MD
-
Use of ctDNA for Molecular Residual Disease Assessment and Immunotherapy Monitoring in NSCLC
Natalie I. Vokes, MD, MPH
-
Five Year Update on ADAURA Clinical Trial of Tagrisso in EGFR Early Stage NSCLC
Charu Aggarwal, MD, MPH
